TipRanks
55% OFF
PC:AECOR

AecorBio Inc

AecorBio Inc. is a US-based biotechnology company specializing in the development of innovative bioactive peptides for therapeutic use in oncology, inflammatory, and autoimmune diseases. The company's proprietary peptide platform has yielded multiple drug candidates, with its lead candidate, FT-002a, targeting advanced prostate cancer. AecorBio's approach involves modulating tumor iron metabolism to enhance treatment efficacy. Supported by a strong intellectual property portfolio and global academic collaborations, AecorBio is advancing a multi-asset pipeline aimed at addressing significant unmet medical needs.

Leadership & Board

Latest Estimated Valuation

Estimated Valuation
$30M
Total Amount Raised
$2M
Total Funding Rounds
1
Latest Funding Amount
$2M
Latest Funding Round
Investment
Post-Money Valuation
$30M

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 17, 2025Investment$1.50M$30.00M

Similar Companies

A snapshot of private companies similar to AecorBio Inc, helping you discover and navigate related company profiles.

Related News and Analysis